President at Sheehan Health Management Corporation
Greater New York City Area
- Current
-
- Consultant at Sanford Health USD Medical Center, Sioux Falls, SD
- Consultant at ev3
- Treasurer at PAD Coalition
- Chair, Cardiometabolic Risk Committee at American Diabetes Association
- Board of Directors at Greystone Pharmaceuticals
- President at Wound Healing Foundation
- Medical Advisory Board at EHE International
- Board of Directors at Wound Healing Society
- Consultant at Heal Or
- shareholder at Hypermed
- shareholder at Hypermed
- Consultant at Biotechnology
- Program Chair at 10th Annual Meeting: Wound Healing: Science and Industry, St Thomas
- President at American Diabetes Association NYC Leadership Board
- President at Sheehan Health Management
- President at Sheehan Health Management Corporation
- Past
-
- Consultant at ev3
- President at Wound Healing Foundation
- President at Wound Healing Foundation
- Board of Directors at Wound Healing Society
- Director, Center of Excellence for the Management of Diabetes at Mount Sinai School of Medicine
- SAB at Advanced BioHealing
- Board of Directors at American Diabetes Association
- Consultant at Calvary Hospital
- SAB at Athenogen
- SAB at Greystone Pharmaceuticals
- Medical Director, Diabetes Foot and Ankle Center at NYU Hospital for Joint Diseases
- Physician Recognition Program Committee at NCQA
- Diabetes Physician Recognition Committee at NCQA
- SAB at Agennix
- Director, Diabetes Treatment Center at Staten Island University Hospital
- Education
-
- Yale University School of Medicine
- State University of New York Downstate Medical Center College of Medicine
- State University of New York Downstate Medical Center College of Medicine
- Connections
-
101
connections
- Industry
- Biotechnology
- Websites
Peter Sheehan, MD’s Summary
Peter Sheehan, MD
Peter Sheehan, MD is a well-respected specialist in the field of Diabetes, Dr. Sheehan’s practice focuses on the cardiovascular and lower extremity complications of the disease. He has a particular research interest in peripheral neuropathy, wound healing, Charcot osteoarthropathy, and peripheral arterial disease. Dr. Sheehan is a graduate of the SUNY-Downstate School of Medicine, where he also completed his residency in Internal Medicine. He continued his training at the Yale University School of Medicine in New Haven where Dr. Sheehan completed a fellowship in Endocrinology and Metabolism.
Dr. Sheehan continues to be actively involved in numerous clinical trials dealing with cardiovasacular disease, wound healing, diabetic neuropathy, and peripheral arterial disease, most recently as Senior Faculty, Mount Sinai School of Medicine. He has worked on both the local and national level with the American Diabetes Association (ADA) where he has served as Chairman of the Council on Foot Care. Dr. Sheehan led a consensus panel on peripheral arterial disease and diabetes sponsored by the ADA and the American College of Cardiology (ACC). Dr. Sheehan has been appointed to the Boards of Directors of the American Diabetes Association, the PAD Coalition, and the Wound Healing Society. In addition, he is presently the Chair of the Cardiometabolic Risk Initiative of the ADA, as well as President of the ADA”s New York City Board.
Dr. Sheehan is interested in helping companies in Biotech, Pharma, Disease Management, and Consulting.
Peter Sheehan, MD’s Specialties:
Diabetes
Wound Healing
Peripheral Arterial Disease
Biotechnology
Disease Management
Clinical Trials
Drug and Device Development
Continuing Medical Education
Peter Sheehan, MD’s Experience
-
Consultant
Sanford Health USD Medical Center, Sioux Falls, SD
(Non-Profit; Hospital & Health Care industry)
2009 — Present (less than a year)
World-class diabetes clinical program
-
Consultant
ev3
(Biotechnology industry)
2009 — Present (less than a year)
-
Treasurer
PAD Coalition
(Hospital & Health Care industry)
2008 — Present (1 year )
-
Chair, Cardiometabolic Risk Committee
American Diabetes Association
(Non-Profit; Non-Profit Organization Management industry)
2007 — Present (2 years )
-
Board of Directors
Greystone Pharmaceuticals
(Hospital & Health Care industry)
2007 — Present (2 years )
-
President
Wound Healing Foundation
(Hospital & Health Care industry)
2007 — Present (2 years )
-
Medical Advisory Board
EHE International
(Hospital & Health Care industry)
2007 — Present (2 years )
-
Board of Directors
Wound Healing Society
(Hospital & Health Care industry)
2006 — Present (3 years )
-
Consultant
Heal Or
(Pharmaceuticals industry)
2006 — Present (3 years )
Drug development wound healing
-
shareholder
Hypermed
(Medical Devices industry)
2006 — Present (3 years )
Shareholder
-
shareholder
Hypermed
(Medical Devices industry)
2006 — Present (3 years )
Shareholder
-
Consultant
Biotechnology
(Pharmaceuticals industry)
2005 — Present (4 years )
In general, device and pharma
-
Program Chair
10th Annual Meeting: Wound Healing: Science and Industry, St Thomas
(Medical Devices industry)
1999 — Present (10 years )
St Thomas, US Virgin Islands
December 11, 12, 13, 2009
Dawn Corntcher, Event Planner -
President
American Diabetes Association NYC Leadership Board
(Non-Profit; Non-Profit Organization Management industry)
1996 — Present (13 years )
-
President
Sheehan Health Management
(Hospital & Health Care industry)
1995 — Present (14 years )
-
President
Sheehan Health Management Corporation
(Biotechnology industry)
1995 — Present (14 years )
Peter is interested in the life sciences investment community and consulting with biotech companies
-
Consultant
ev3
(Hospital & Health Care industry)
2009 — 2009 (less than a year)
-
President
Wound Healing Foundation
(Biotechnology industry)
2007 — 2009 (2 years )
-
President
Wound Healing Foundation
(Biotechnology industry)
2007 — 2009 (2 years )
-
Board of Directors
Wound Healing Society
(Biotechnology industry)
2006 — 2009 (3 years )
-
Director, Center of Excellence for the Management of Diabetes
Mount Sinai School of Medicine
(Educational Institution; Research industry)
2007 — 2008 (1 year )
-
SAB
Advanced BioHealing
(Privately Held; Biotechnology industry)
2006 — 2008 (2 years )
-
Board of Directors
American Diabetes Association
(Hospital & Health Care industry)
2005 — 2008 (3 years )
-
Consultant
Calvary Hospital
(Hospital & Health Care industry)
2004 — 2007 (3 years )
-
SAB
Athenogen
(Medical Devices industry)
2004 — 2006 (2 years )
Drug development, IND filing, clinical trial
-
SAB
Greystone Pharmaceuticals
(Pharmaceuticals industry)
2003 — 2006 (3 years )
-
Medical Director, Diabetes Foot and Ankle Center
NYU Hospital for Joint Diseases
(Non-Profit; Hospital & Health Care industry)
2000 — 2006 (6 years )
Created highly successful program still yielding clinical and financial benefits
-
Physician Recognition Program Committee
NCQA
(Non-Profit; Hospital & Health Care industry)
2000 — 2006 (6 years )
ADA sponsored committee on performance measuresfor diabetes care
-
Diabetes Physician Recognition Committee
NCQA
(Non-Profit; Hospital & Health Care industry)
2000 — 2006 (6 years )
Creation of performance measures for improved monitoring of quality of diabetes care
-
SAB
Agennix
(Medical Devices industry)
2003 — 2005 (2 years )
Resaerch, drug development, FDA IND
-
Director, Diabetes Treatment Center
Staten Island University Hospital
(Non-Profit; Hospital & Health Care industry)
1996 — 1999 (3 years )
Peter Sheehan, MD’s Education
-
Yale University School of Medicine
Endocrinology and Metabolism 1984 — 1986
-
State University of New York Downstate Medical Center College of Medicine
Internal Medicine 1981 — 1984
-
State University of New York Downstate Medical Center College of Medicine
1977 — 1981
Additional Information
Peter Sheehan, MD’s Websites:
Peter Sheehan, MD’s Groups:
-
Wireless Health
Peter Sheehan, MD’s Honors:
http://www.dlsconference.com/award.html
Peter Sheehan, MD’s Contact Settings
Interested In:
- career opportunities
- consulting offers
- new ventures
- expertise requests
- business deals
